Real World Evidence Studies in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Real World Evidence Studies in Argentina

Real World Evidence Studies in Argentina – Clinical Trials in LATAM

In the dynamic world of healthcare research, Real World Evidence (RWE) studies have emerged as a revolutionary approach to understanding the real-world effectiveness, safety, and economic implications of medical interventions.

Particularly in a diverse and complex country like Argentina, Real World Evidence studies hold immense potential to shape healthcare policies, improve patient outcomes, and propel medical research to new heights. This blog post delves into the significance of Real World Evidence studies in Argentina and how they can transform healthcare decision-making.

Understanding Real World Evidence Studies:

While traditional clinical trials serve as the gold standard for evaluating treatment efficacy, they often take place in controlled environments that may not fully mirror real-world scenarios. Real World Evidence studies, in contrast, tap into a diverse range of data sources, including electronic health records, insurance claims, and patient registries.

By analyzing this real-world data, researchers can gain insights into how treatments perform under various conditions, accounting for patient demographics, comorbidities, and healthcare practices.

Argentina’s Unique Healthcare Landscape:

Argentina’s healthcare system is characterized by a mix of public and private healthcare providers, striving to ensure access to quality care for its citizens. However, disparities in healthcare delivery exist between urban and rural areas, making the need for tailored healthcare solutions more pressing. Argentina’s diverse population, which encompasses various ethnicities and socioeconomic backgrounds, adds another layer of complexity to the healthcare landscape.

The Role of Real World Evidence Studies in Argentina:

Real World Evidence studies hold remarkable promise within Argentina’s healthcare ecosystem. Firstly, they offer insights into treatment effectiveness that resonate with the country’s diverse population.

This is particularly valuable for conditions that may manifest differently across various ethnic groups or geographic regions. By analyzing real-world data, researchers can uncover treatment outcomes that may not have been apparent in controlled clinical trials.

Secondly, Real World Evidence studies play a pivotal role in shaping healthcare policies and guidelines. Decision-makers can harness these insights to allocate resources optimally, tailor interventions to specific population segments, and elevate the overall quality of healthcare delivery.

For instance, if Real World Evidence suggests that a certain treatment is more effective among a certain demographic, healthcare providers can adjust their approach accordingly, leading to improved patient outcomes.

Furthermore, Real World Evidence studies provide crucial information about the economic impact of healthcare interventions. By analyzing data on resource utilization, costs, and patient outcomes, policymakers can make well-informed decisions about which interventions offer the best value for money. This becomes especially relevant in a country like Argentina, where optimizing resource allocation is crucial.

Real World Evidence Studies in Argentina

Real World Evidence Studies in Argentina

Real World Evidence Studies in Argentina

Challenges and Considerations:

Despite their potential, Real World Evidence studies come with their set of challenges. Ensuring data quality and protecting patient privacy are paramount. Proper data anonymization and security protocols are essential to maintain ethical standards and patient trust. Collaboration between healthcare institutions, researchers, and policymakers is key to overcoming these challenges effectively.

Moreover, standardizing data collection methods and definitions across diverse healthcare providers and regions can be complex. However, initiatives aimed at harmonizing data can enhance the reliability and comparability of Real World Evidence studies.

A Collaborative Approach:

To fully unlock the potential of Real World Evidence studies in Argentina, collaboration among stakeholders is imperative. Researchers, healthcare providers, policymakers, and patients need to collaborate to establish a robust framework for data collection, analysis, and application.

Investments in health information technology can facilitate the collection and sharing of electronic health records, enabling comprehensive and timely data analysis. Regulatory bodies can play a role in promoting and guiding RWE research, ensuring ethical standards are upheld.

Additionally, public awareness campaigns are essential. Patients should understand the value of their data in advancing healthcare research and should have the choice to participate or opt out with full transparency.


Real World Evidence studies have the potential to reshape healthcare decision-making in Argentina by offering insights that mirror real-world patient experiences and outcomes. These studies enable informed decisions that are tailored to Argentina’s unique healthcare landscape.

As the country strives for a more efficient and equitable healthcare system, embracing Real World Evidence studies can lead to enhanced treatment guidelines, improved patient care, and optimized resource allocation. Through collaborative efforts and a commitment to data integrity, Argentina can harness the power of Real World Evidence for the betterment of its population.

Real World Evidence Studies in Argentina

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Real World Evidence Studies in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Real World Evidence Studies in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Real World Evidence Studies in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Real World Evidence Studies in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Real World Evidence Studies in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Real World Evidence Studies in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Real World Evidence Studies in Argentina

The Cohortias Team

Real World Evidence Studies in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Real World Evidence Studies in Argentina

Network & Partnerships